Rajasthan Govt returns 25% of Hydroxychloroquine stocks amidst huge demand from other patients
The Rajasthan government has decided to return 25 per cent of hydroxychloroquine tablets that it had acquired from distributors, stockists and others for managing Coronavirus infected patients.
Hydroxychloroquine, a cheap anti-Malaria drug is considered useful to treat COVID-19 patients and some other diseases as well.
The decision to return some stock of the drug was taken as some arthritis patients were facing difficulty to get it from the market.
A PTI report quoting Additional Chief Secretary (Health) Rohit Kumar Singh said the Health Department had acquired Hydroxychloroquine 200, 300 and 500mg tablets from C&F, distributors, stockists, wholesalers and retailers in public interest as the medicine is used in COVID-19 infection treatment, However, due to this regular patients could not get the medicine in market.
He said that these medicines should be made available to patients on the basis of medical consultation and there should be no black marketing and profiteering.
In another order, Singh instructed that all Ayurveda, Homeopathy and Unani Medical Officers and Compounders of the state will work under the Medical and Health Department till further orders.
Singh said the decision has been taken in the wake of the COVID-19 pandemic.
post_id:uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
